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Objective
Protein-lipid interactions mediate many essential cellular functions.  Though these
interactions are common, very little is known about the specific determinants modulating
these interactions.  To help better understand the specific requirements of these binding
events, we are employing the use of synthetic micelle mimics.  The goal of this C500
project was to examine the binding affinity of human profilin I and a branched polymer
with 52 PIP2 headgroups.  Additionally, a biotinylated branched polymer with 7 PIP2
headgroups has been constructed to be used in subsequent binding studies.
Introduction
Phospholipids are crucial components of cellular membranes.  One particular type
found is phosphoinositides (PIPn).  These lipids are composed of an inositol headgroup, a
glycerol backbone, and two fatty acid chains (typically stearic and arachidonic acid)
(Figure 1)1.  The inositol headgroup displays five hydroxyl groups which can potentially be
phosphorylated.  Many variations of phosphoinositides are present in the cellular
membrane including PI(3)P, PI(4)P, PI(5)P, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, and
PI(3,4,5)P3 .  These are interconverted by kinases and phosphatases depending on cell
needs for various signal transduction pathways1.  Processes such as membrane targeting,
channel gating for release of intracellular calcium, G protein activation, endocytosis,
apoptosis, and cell growth and motility are regulated by phosphoinositides (Figure 1)2,3.
Phosphatidylinositol-4,5-bisphosphate (PIP2), the most abundant phosphoinositide,
constitutes approximately 1% of all lipids in the plasma membrane4,5.  Cleavage by
phospholipase C yields the important second messengers inositol (3,4,5) triphosphate (IP3)
and diacylglycerol (Figure 1).  Though PIP2 is essential for many cellular functions, little is
known about the mechanism of its interactions.
Along with having many functions, PIP2 is recognized by numerous binding
domains including PH, PX, FERM, ANTH, ENTH, Tubby, and MARCKS6,7.  These
domains are structurally diverse, yet all bind to PIP2 and other phosphoinositides.  For
example, PH domains, one of the most commonly found, are highly involved with
signaling and cytoskeletal functions and contain clusters of basic residues thought to be
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involved with binding8.  A second example is the FERM domain which is characterized by
a cloverleaf shape composed of three domains and functions mainly as cross-linkers for the
membrane to actin filaments.  Crystallographic studies suggest that PIP2 binds in a basic
cleft between two of the subunits6.  Yet another example is the ENTH domain which is
important for membrane remodeling.  Binding by PIP2 causes a conformational change in
the N terminus, creating a helix involved with membrane insertion6.  The involvement with
so many different structural features shows the need to understand these interactions on a
more detailed level.
PIP2 also plays a major role in the regulation of the actin cytoskeleton through
interactions with key regulating proteins such as WASP-SCAR, gelsolin, cofilin, and
profilin3.  The conversion of globular ATP-actin to filamentous ADP-actin is mediated
through interactions with these proteins.  PIP2 aids with both promotion and prevention of
actin polymerization3.  One of the better characterized PIP2 binding partners is profilin, a
Figure 1.  The structure and importance of phosphoinosides in the cell.  Figure adapted from thesis of
S.A. Webb9.
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15 kDa globular protein.  This protein is found as both a peripheral membrane and
cytosolic protein10.  Like PIP2, it can either act to promote or inhibit actin
polymerization11.  These interactions play a role in cytoskeletal arrangement and cellular
motility.  Improper functioning and low levels of profilin can lead to tumor formation12.
Therefore, properly understanding these interactions and pathways may play a crucial role
in treatments and cures.
Though profilin is well characterized, its binding sites for PIP2 are not agreed on.
There is evidence for several binding sites for PIP2 on profilin.  One potential site is Arg
88 which was implicated through mutagenesis studies13, while another site is Arg 135 and
136.  Photoaffinity labels along with computer modeling were used to elucidate this site14.
Generally the binding sites are thought to be located in a highly basic region of the protein
potentially close to the terminal ends (Figure 2)14-17.  Evidence also suggests that the PIP2
and actin binding sites overlap18.  This would account for the experimental data which
shows PIP2 and actin compete for binding with profilin18.  Upon binding with PIP2, profilin
no longer can bind to actin.  Experimental evidence suggests that PIP2 binds to profilin in
a multivalent manner.  Gel filtration studies indicate that PIP2 and profilin bind in a 5:1
ratio respectively19.  Though profilin binds to PIP2, experimental data suggests
Figure 2.  The structure of human profilin I.  Residues implicated in binding are shown in purple.  A
phosphate molecule is indicated in orange and red and was crystallized with the protein.  Figure prepared
in protein explorer using 1FIK.
Arg 135, 136
Arg 88
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that it does not bind to its hydrolysis product IP320, suggesting that the interaction with
only one polar headgroup is not sufficient for binding to occur.  Additionally, it has been
shown that high salt buffer dissociates the profilin PIP2 interaction and upon profilin
binding to PIP2, there is no gross disruption of micellar structure10,20. This data suggest a
multivalent binding mechanism.  Though it is not clear or agreed upon by others, our
hypothesis is that multivalency is essential for the binding mechanism between PIP2 and
profilin.  Potentially, more than one PIP2 molecule is needed for recognition by profilin
(Figure 3).  Multivalency is not an uncommon method of recognition as there are many
examples relevant to human biology.  For example, influenza and E.Coli both adhere to
cell surfaces through multivalent recognition21.  Additionally neutrophils respond to
inflammation in a similar manner21.  Yet another example involves the multivalent binding
of certain transcription factors to DNA21.
One way to study this multivalent interaction is by the use of PIP2 reconstituted in
micelles or vesicles.  However, this presents several problems.  Membrane-like
environments such as micelles or vesicles are highly dynamic and fluid.  With so much
freedom in movement, it would be hard to decipher the orientation and arrangement of
Figure 3.  Schematic representation of multivalent interaction between profilin and PIP2.
Figure shows profilin in blue binding to a micelle of PIP2 with headgroups shown in yellow and lipid tails
in green.  It can be seen that multiple headgroups are binding to profilin in the right portion of the figure.
the PIP2 headgroups upon binding to profilin.  One way to circumvent this problem is
through the use of a covalent scaffold of PIP2 molecules.  Synthetic multivalent
representations of molecules have been documented in the literature including multivalent
carbohydrate ligands showing shiga toxin inhibition and multivalent saccharide dendrimers
proficient in glycoside clustering22,23.
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We have initiated a plan for investigating the PIP2 profilin interaction by using
modified PAMAM dendrimers24.  By using a commercially available core and a linker
moiety, synthetic PIP2 headgroups have been covalently attached to the termini (Figure 4).
The initial work was carried out in the Oakley lab by Sarah A. Webb9, in which she
determined a squarate linker to be the most efficient coupling reagent for the PIP2
headgroup.  Much of her work also focused on the order of the chemistry and the
synthesis of the PIP2 headgroup.  This synthetic PIP2 micelle mimic will allow for more
control over the spatial arrangement and number of PIP2 headgroups presented than in a
natural micelle or vesicle.  Shown in Figure 4 is a generation 0 (G0) micelle mimic with 4
termini.  Larger dendrimers have also been synthesized in the lab including G1 (8
headgroups) and G4 (~52 headgroups)25.
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Figure 4. Synthetic PIP2 generation 0 micelle mimic.
With initial synthetic challenges met, we are currently working on synthesizing
variations of the PIP2 dendrimer and methods of binding to examine the interaction with
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profilin.  Our goal is to characterize the binding interaction and test whether multivalency
is important for binding.  From this information, we will be able to compare the binding of
the natural substrate PIP2 and IP3 to that of the synthetic micelle mimics.  Our expectation
is that the dendrimers will bind as well as PIP2 and better than IP3.  However, since the
required arrangement of PIP2 headgroups for binding is unclear, it may take several
iterations to achieve binding as tight as that of the natural substrate PIP2.  This will give us
an insight as to what is required for selective binding to profilin.  Ideally, this information
should allow us to design dendrimers which bind specifically to profilin and thus can be
used for biological studies.  Here, I will present the synthesis of a biotinylated G1 PIP2
micelle mimic and also the various binding methods that are being used the interaction of a
G4 PIP2 micelle mimic with profilin.
Materials and Methods
Wild Type Protein Expression and Purification
 Wild type human profilin was expressed using a T7 bacteriophage expression
system26.  Briefly, 50?L of BL21(DE3) E.coli cells were placed on ice to thaw for 10
minutes.  Next, 2-3 ?L of the plasmid containing the pMW172 HPP gene were added to
the cells and allowed to sit on ice for 30 minutes.  Next the cells were heat shocked at
42oC for 45 seconds and immediately placed on ice again for a few minutes.  After adding
250 ?L of SOC medium, 200 uL were plated on ampicilliin plates (100 ?g/mL).  The
plates were grown up overnight at 37oC.  Cultures were inoculated from a single colony.
After growing overnight (12-16 hours) at 37oC and 225 rpm, the 4 mL of cells were added
to a larger culture of 700 mL LB and 700 ?L of ampicilliin.  The cultures were incubated
with shaking at 225 rpm for 10-16 hours at 37oC and then harvested by centrifugation at
5000 rpm for 15 minutes in a JA-10 rotor.  Next the cells were resuspended in 12 mL of
buffer A (10 mM Tris, 40 mM KCl, 1 mM BME pH 7.4).  To this, 100 ?L of DNAse (10
mg/mL) in 100 mM MgCl2 and 100 ?L of PMSF were added.  The cells were then lysed
by sonication using a 10 minute cycle of 30 seconds on/30 seconds off.  This was followed
by centrifugation for 15 minutes at 12,000 rpm in a JA-20 rotor.  The supernatant was
collected for later analysis and the pellet was resuspened in another 12 mL of buffer A.
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The sonication procedure was then repeated.  Next the supernatants collected were loaded
onto a poly-L-proline affinity column equilibrated in buffer A at 4oC.  First the column was
washed with 60 mL of buffer A and then 120 mL of buffer A with 3 M urea.  Then the
column was allowed to warm to room temperature and the protein was eluted with 60 mL
of buffer A with 8 M urea.  The fractions collected were analyzed by SDS-PAGE using a
polyacrylamide gel composed of 16% resolving gel and 5% stacking gel.  A polypeptide
molecular weight marker from Bio-Rad was used to identify fractions containing profilin.
These fractions were then pooled and concentrated using Amicon centrifugation tubes
(1000 MWCO).  The samples were subjected to centrifugation at 3000 rpm in the JA-10
rotor for four hours.  Next the sample was dialyzed in degassed buffer A in a 1000
MWCO dialysis tube for 4-5 hours with 1-2 buffer changes.  The purified protein was then
analyzed by SDS-PAGE and MALDI-TOF mass spectrometry.
HTN Profilin Expression and Purification
 To express WT profilin with an N-terminal his tag, the pMW172 HPP gene was
cloned into a pET-28a(+) vector.  First a reaction was set up with 3.5 ?L pET-28a(+), 4.0
?L of pMW172 HPP, 2 ?L Eco R1 10x buffer, 1 ?L of both EcoR1 and Nde1 restriction
enzymes, and 8.5 ?L of ddH2O.  The reaction was incubated at 37oC overnight.  The next
day the DNA was ligated back together by adding the following to the reaction: 1 ?L
DNA ligase, 2 ?L T4 DNA ligase buffer, and 0.2 ?L 100 mM dATP.  The reaction was
incubated for 1 hour at room temperature.  Afterwards, the ligase was deactivated by
heating the reaction to 65oC for 10 minutes.  The ligation product was subjected to
digestion using the restriction enzyme BamH1 to cleave any remaining original pET
vector.  The DNA was then transformed using the same procedure as in the previous
section except kanomycin plates were used.  Sequencing of the plasmid DNA isolated
from a single colony of transformed confirmed that the protein did in fact have the N-
terminal his tag.  The protein was expressed using the same procedure as above.  After
harvesting the cells, 3.8g of pellet were resuspended in 20 mL of lysis buffer containing 50
mM NaH2PO4, 300 mM NaCl, and 10 mM imidazole, pH 8.0.  PMSF and DNAse were
also added and the cells were sonicated as above.  The protein was then purified using a
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Ni-NTA column at 4oC.  The column was equilibrated with 5 column volumes of lysis
buffer and the lysate was loaded onto the column.  The column was washed with 75 mL
buffer containing 50 mM NaH2PO4, 300 mM NaCl, and 20 mM imidazole, pH 8.0.  Next
the protein was eluted with the same buffer, but containing 250 mM imidazole.  The
fractions were analyzed for protein using SDS-PAGE and then combined and dialyzed into
degassed buffer A using 1000 MWCO dialysis tubing for 4-5 hours with 1-2 buffer
changes.  As above, the purified protein was then analyzed by SDS-PAGE and MALDI-
TOF mass spectrometry.
Surface Plasmon Resonance (SPR) Experiments
 SPR binding experiments were carried out using a BIAcore 3000.  The WT
profilin was covalently attached to a CM4 chip using a 4:1 mixture of 0.12 M N-
hydroxysuccinimide (NHS) and 0.39 M N-ethyl-N’-(dimethyl-aminopropyl)carbodiimide
hydrochloride (EDC) at 20oC.  Buffer and pH studies with the protein indicated sodium
acetate pH 5.0 to be the most appropriate coupling buffer.  Therefore, the protein was
dialyzed into this buffer prior to all BIAcore experiments.  An attempt to couple the PIP2
headgroup was carried out in the same way according to the procedure of Prestwich27.
The N-terminal his tagged protein was immobilized to the surface of an NTA chip at 4oC.
The chip was first activated with Ni2+ followed by injection of the protein.  Micelles and/or
vesicles were made according to the procedure of Machesky28 and then passed over the
chip to examine binding.
Isothermal Titration Calorimetry (ITC)
 ITC experiments were carried out on a Microcal VP-ITC instrument using Origin
software to analyze the data.  The WT profilin (131 ?M, 0.4 mL) was titrated into a
reservoir containing 1.8 mL of 30 ?M PIP2 vesicles.  Vesicles were made as described
above.  Prior to the experiment both the protein and vesicles were dialyzed exhaustively
into 10 mM tris, 40 mM KCl, pH 7.5 using 3500 MWCO dialysis tubing.
Binding Filtration Assay
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This procedure has been modified from that of Lambrechts29.  PIP2 vesicles were
made as described above.  Increasing concentrations were incubated with the WT protein
in 10 mM tris, 40 mM KCl, 1 mM BME, pH 7.4 for 30 minutes on ice.  Next the samples
were subjected to centrifugation at 2000g for 2.5 minutes in a Millipore microcon filter
with a 100 kDa MWCO.  Then the filters were flipped over and centri at 1000g for 1
minute to collect any protein remaining on top.  The assay was also done with the G4 PIP2
dendrimer in the same way except a 50,000 MWCO filter was used and the samples were
subjected to centrifugation at 3500g for 4 minutes.  After centrifugation, all samples were
brought to the same volume with buffer and 10 ?L was taken to assay on a polyacrylamide
gel (16% resolving, 5% stacking).  To the sample, 10 ?L of SDS loading dye (62.5 mM
Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 0.01% bromophenol blue) was added and also 1
?L of either APH BHis (protein created in the lab, MW = 7550 Da) or PMSF treated
bovine trypsinogen (1 mg/mL, Sigma) to use as a standard to account for gel loading
errors.  After running the gels at 170 V for 45 minutes, they were stained using a
fluorescent SYPRO Ruby dye according to the procedure from the manufacturer30 and
imaged using a Typhoon 9210 (Amersham Biosciences).  A green laser (532 nm) was used
with a 610BP30 emission filter.  Imagequant was then used to analyze the band intensities.
Synthesis of Biotinylated G1 PIP2 mimic
Biotinylated squarate tether31 (1):  A synthetic biotin tether was prepared according to the
procedure of Nelson32.  3,4-diethoxy-3-cyclobutene-1,2-dione (586 ?L, 3.96 mmol) was
dissolved in 19.8 mL DMF.  Biotin tether (443 mg, 0.99 mmol) was added slowly over 10
minutes and reaction was stirred under inert atmosphere at room temperature overnight.
Reaction was concentrated in vacuo and purified via flash chromatography (100:1
CHCl3/TEA to 400:50:1 CHCl3/MeOH/TEA).  The product was characterized using
MALDI mass spectroscopy and one and two dimensional 1HNMR (Yield:  53%, 298 mg,
0.522 mmol). 1H NMR (D2O) ?:  4.70-4.60 (m, 3 H), 4.60-4.52 (m, 1 H), 3.70-3.50 (br
m, 14 H), 3.32-3.18 (m, 3 H), 2.99-2.90 (dd, 1 H), 2.75-2.68 (dd, 1 H), 2.25-2.15 (t, 2
H), 1.90-1.80 (m, 2 H), 1.80-1.45 (br m, 6 H), 1.45-1.30 (m, 5 H).  MALDI-TOF:
Calculated for C28H46N4O8S: 570.70; found (MH+): 571.41.
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Biotinylated G1 PAMAM dendrimer (2):    G1 PAMAM dendrimer (10 mg, 0.007 mmol)
was reacted with 1 (3.4 mg, 0.006 mmol) in 250 ?L DMF.  The reaction was stirred under
inert atmosphere at room temperature overnight.  Product was purified by reverse phase
C18 HPLC (15-25% CH3CN over 60 min gradient with 10 min hold in beginning at 10%
CH3CN, monitored at 280 nm).  The product was characterized using MALDI mass
spectroscopy and 1HNMR (Yield:  36.4%, 5.1 mg, 0.003 mmol). 1H NMR (D2O) ?:
4.55-4.48 (m, 1 H), 4.35-4.30 (m, 1 H), 3.70-3.50 (m, 14 H), 3.50-3.45 (t, 2 H), 3.45-
3.38 (t, 16 H), 3.36-3.30 (t, 2 H), 3.30-3.18 (br m, 10 H), 3.18-3.13 (t, 2 H), 3.12-3.02 (t,
16 H), 2.96-2.55 (br m, 36 H), 2.50-2.30 (br m, 20 H), 2.20-2.12 (t, 2 H), 1.90-1.75 (m, 2
H), 1.75-1.40 (m, 6H), 1.40-1.25 (m, 2 H).  MALDI-TOF: Calculated for
C86H164N30O19S: 1954.47; found (MH+): 1955.18.
Biotinylated G1 squarate PAMAM dendrimer (3): 2 (21 mg, 0.0107 mmol) was dissolved
in 280 ?L DMF.  3,4-diethoxy-3-cyclobutene-1,2-dione (55.6 ?L, 0.376 mmol) and
diisopropylethylamine (65.5 ?L, 0.376 mmol) were added to the reaction.  The reaction
was stirred at room temperature for 4 hours and then concentrated in vacuo.  The mixture
was then purified using Bio-Rad Bio-Gel P2 polyacrylamide size exclusion gel.  The
column was equilibrated in 20% ethanol and the sample was loaded in 500 ?L of 20%
ethanol.  Fractions were assayed with UV light to isolate the desired compound.  The
product was characterized by ESI mass spectroscopy and one and two dimensional
1HNMR (Yield:  35%, 10.5 mg, 0.0037 mmol). 1H NMR (D2O) ?:  4.70-4.55 (m, 14 H),
4.55-4.50 (m, 1 H), 4.35-4.30 (m, 1 H), 3.70-3.45 (br m, 30 H), 3.45-3.15 (br m, 27 H),
3.10-2.25 (br m, 63 H), 2.22-2.12 (t, 2 H), 1.90-1.40 (m, 8 H), 1.40-1.25 (m, 23 H).  ESI:
Calculated for C128H192N30O40S: 2823.14; found:  2824.00.
Biotinylated G1 PIP2 dendrimer (4): 3 (5 mg, 1.77 x 10-3 mmol) was dissolved in 110 µL
0.1 M NaHCO3 pH 9 with the previously prepared PIP2 headgroup9 (14.6 mg, 0.0248
mmol).  The reaction was stirred at room temperature for 6 days and monitored by
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1HNMR.  The product was purified by dialysis (1000 MWCO) and is currently being
characterized by ESI mass spectrometry and NMR.
Results and Discussion
The goals of my C500 project were to examine the binding interaction between the
dendrimers and profilin and also to work on the synthesis of the biotinylated PIP2 micelle
mimic.  Specifically I worked on investigating the binding between profilin and the G4
PIP2 micelle mimic.
Surface Plasmon Resonance (SPR): Coupling of PI(4,5)P2 headgroup analog
Initially I tried covalently coupling the PI(4,5)P2 headgroup analog to a BIAcore
CM4 sensor chip.  The plan was to then flow WT profilin over the surface and monitor
binding.  The chip is composed of a stable carboxymethylated dextran matrix.  The matrix
was first activated using a mixture of NHS and EDC.  Next the PIP2 headgroup in water
pH 5-6 was injected over the surface at a neutral pH according to the procedure of
Prestwich27.  Binding studies showed that WT profilin did not bind to the chip.  There are
a few possible reasons for the WT protein’s inability to bind.  First, there may not have
been any PIP2 headgroup coupled to the chip for it to bind.  Additionally, the few PIP2
headgroups that may have been coupled to the chip might not have been in close enough
proximity to one another to present a multivalent array to facilitate binding with profilin.
Lastly, the whole lipid may be required for profilin binding.  Additional attempts at
coupling the headgroup proved problematic and it was found that regeneration conditions
found by Prestwich27 did not work in our hands.  At this point, I decided to attempt
coupling the protein instead of the PIP2 headgroup using a different coupling method.
SPR: Coupling of HTN profilin
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Modification of WT profilin afforded the protein with an N-terminal his6x tag.  I
attempted to couple this protein to a BIAcore NTA sensor chip.  This chip presented a
carboxymethylated matrix immobilized with nitrilotriacetic acid (NTA).  When coupled
with Ni2+, chelation with the his-tagged protein takes place.  Attempts to couple the HTN
profilin showed the protein could be chelated to the surface of the chip, but was not stable
at room temperature and leached off in a dissociative manner.  Subsequent studies
showed the protein to be stably chelated to the surface of the chip at 4oC.  However, it
was found that PIP2 micelles did not bind to the protein.  This can be seen in Figure 5.
Figure 5. BIAcore sensorgram showing capturing of HTN profilin and subsequent injection of PIP2
micelles.
After an injection of Ni2+, HTN profilin was immobilized onto the surface of the chip.
Upon injecting PIP2 micelles, no increase in response was seen which would indicate
binding.  This in not entirely surprising as one of the PIP2 binding sites is postulated to be
near the terminal ends of the protein29.  The introduction of a his-tag may have had a
disruptive effect on binding.
SPR: Coupling of wildtype profilin
Next, I coupled the wild type protein to the surface of the CM4 chip using the
EDC-NHS chemistry described above.  Essentially the protein was coupled in a
heterogeneous array through intrinsic amine groups.  This method provided for an easy
and quick immobilization of the protein and did in fact show promising binding data with
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PIP2 micelles.  An example binding curve of wild type profilin with PIP2 micelles is shown
in Figure 6.  The start of the injection of PIP2 and the association phase is indicated by
arrow 1 while the end of the injection and start of the dissociation phase is indicated by
arrow 2.
Though it was easy to see initial binding results other aspects of the experiment
proved difficult such as regeneration, protein, PIP2 micelle stability, and reproducibility.  A
regeneration step is important for dissociating any remaining ligand from the surface of the
chip to yield the original surface unharmed.  Conditions must be found which are harsh
enough to remove all of the bound PIP2 micelles, yet are mild enough not to inactivate or
permanently damage the wild
Figure 6. BIAcore sensorgram showing injection and binding of PIP2 micelles to wild type profilin.
Arrow 1 indicates the beginning of the injection and the association phase while the end of the injection
and start of the dissociation phase is indicated by arrow 2.
type protein.  The following chemicals were tested for their regeneration capabilities: urea,
glycine, sodium hydroxide, guanidinium HCl, sodium chloride, and ethanolamine.
Ultimately of these solutions tried, 1 M ethanolamine seemed to give the best results.
Over multiple runs of binding and regeneration, the baseline level (amount of profilin
immobilized) and the response level (amount of PIP2 binding) remained essentially the
same.
Though initial kinetic results were obtained in one experiment, fitting the data
proved difficult and all available flow cells had been used.  This would have altered the
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available PIP2 to the flow cell I was actually studying since some PIP2 might have bound in
other flow cells and also caused an apparently slower dissociation constant.  Due to time
constraints the experiment could not be repeated for a week.  At this time it was found
that the PIP2 had gone bad and was no longer binding to the CM4 chip used or one which
had been freshly derivatized with profilin.  Upon obtaining new PIP2, I still found
diminished binding to the CM4 chip derivatized with profilin one month earlier, 150 RU
initially vs. 15 RU one month later.  After subjecting the chip to multiple cleaning steps
involving the use of 1 mM dithiothreitol (DTT), I was able to regain approximately one
third of the initial binding.  Shown in Figure 7 is the regained binding after 5 injections of
PIP2 where the profilin on the chip has been exposed to DTT in between injections.  It
clearly shows that the more the chip is exposed to DTT, the more PIP2 binding is
regained.  This would indicate that over time during storage profilin on the chip had
undergone oxidation thereby preventing it from being able to bind to PIP2 micelles.
Isothermal Titration Calorimetry (ITC)
As an alternative to the SPR experiment, we decided to attempt isothermal
titration calorimetry (ITC) to examine binding.  In this experiment, I titrated wild type
profilin into vesicles composed of PIP2/PC (1:5).  For this experiment to work, the
interaction of interest must have a large enough enthalpy of binding to be above the
limiting sensitivity of the instrument.  I found that the interaction of profilin with PIP2
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Figure 7. BIAcore sensorgram showing regained binding of PIP2 micelles as profilin is repeatedly
exposed to 1 mM DTT.  Injection 1 081204 is prior to any DTT exposure while injections 1 081304 and 2
are after one DTT exposure, injections 3 and 4 are after 2 DTT exposures and injection 5 is after 3 DTT
exposures.
was not in fact above this cut off for the concentrations I was studying.  Initially a
tris(hydroxymethyl) aminomethane buffer was used for the experiment which has a large
enthalpy of ionization.  If the binding between profilin and PIP2 has a large enthalpy in the
opposite direction, it would be possible for the enthalpy of the buffer to cancel out the
enthalpy of the binding interaction.  Therefore, the interaction was also examined in a
cacodylate buffer.  This buffer’s enthalpy of ionization was nearly zero.  However, similar
results were obtained as previously.  In order to get a better signal, it was determined that
much higher quantities of PIP2 and profilin would be needed.
Binding Filtration Assay
After spending large amounts of time on complicated techniques such as SPR and
ITC, we sought to find a simpler, faster assay to examine binding.  Based on an
experiment done by Lambrechts, et al29, we decided to study the binding between profilin
with PIP2 and the G4 dendrimer using a binding filtration assay.  In this assay bound and
free profilin were separated by a membrane with a MWCO under a centrifugal force
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(Figure 8).  After incubating the protein and dendrimer to allow for binding, the sample
mixture is loaded into a centrifuge tube containing the dialysis membrane and spun for a
specified amount of time at a predetermined speed.  Any unbound profilin will be small
enough to pass through membrane during centrifugation, while bound profilin will be
larger than the membrane MWCO and will not pass
Figure 8. Demonstrates the filtration binding assay employed in our study of profilin-PIP2 micelle mimic
interaction.
through.  By analyzing multiple samples with increasing amounts of dendrimer and by
using SDS-PAGE, a binding curve can be obtained.  Though this is not an equilibrium
assay, our hopes were to attain a rough idea of the binding magnitude which then would
later be refined by one of the more sophisticated methods (ex. SPR) for examining binding
interactions.
Initially, I was not able to reproduce the data from the literature.  I found that the
time required to pass profilin through the membrane when in the presence of PIP2/PC
vesicles was longer than that reported29.  However, in the literature micelles of PIP2 were
used and a 30 kDa MWCO filter, whereas I was using PIP2/PC vesicles and a 100 kDa
MWCO filter.  At this point, I began to focus more on the binding between profilin and
the G4 PIP2 micelle mimic and did not further optimize the assay for the profilin PIP2
Dialysis Membrane
Load sample in top
After centrifugation , bound and free profilin are separated
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interaction.  Experiments done by Sarah Richer indicated that profilin could pass through a
50 kDa MWCO filter and did not pass through a 30 kDa MWCO filter.  Therefore, 50
kDa MWCO was used in all subsequent experiments with the G4 dendrimer.  Initial
optimization experiments indicated that spinning the samples at 7000 g for 4 min would
efficiently transfer most profilin through when no dendrimer was present and also retain
much of the profilin-dendrimer complex when dendrimer was present.  By using these
conditions, I was able to obtain reasonable data which can be seen in Figure 9.  The left
side of the figure shows that as the concentration of G4 is increased, the amount of free
profilin decreases.  The right side shows that as the concentration of G4 is increased the
amount of bound profilin increases.  These results give evidence for a binding interaction
taking place.
From this data, binding curves were obtained shown in Figure 10.  It clearly shows
that as more G4 PIP2 micelle mimic is added, the amount of bound profilin increases while
the amount of free profilin decreases.  However, upon further use of the filters, I could not
repeat the fortuitous results seen in Figure 10.  Later experiments indicated that the
reproducibility between filters was very poor.  Some filters would allow most profilin
through with no G4 present, while other would hardly allow any through under the same
conditions.  A comparison of all experiments done thus far reveals the following graphs
seen in Figure 11.  It is clear from these graphs that there is much inconsistency involved
with the different filters used for each trial.
Free Profilin
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Bound Profilin
Increasing [G4]
Standard
Protein
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Figure 9. SDS-PAGE gel showing filtration binding assay results of profilin and G4 PIP2 micelle mimic.
Lanes 1 through 7 show free profilin which passed through the filter in the presence of increasing
concentrations of G4.  The last 6 lanes show bound profilin which remained on the top of the filter as the
concentration of G4 was increased.  The other band is a protein that was added to account for loading
errors.
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Figure 10. Binding curves obtained by analyzing band intensities on a Typhoon imager.  The top curve
shows that as G4 is added the amount of bound profilin increases, while the bottom curve shows that as
G4 is added the amount of free profilin decreases.
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As a last resort and attempt to eliminate error from filter to filter, our experimental
evidence showed the error could be reduced by reusing one filter up to approximately 6
times.  Upon trying this experiment with G4 and profilin, Sarah and I randomly chose 14
filters and passed profilin only through them.  Next we ran polyacrylamide gels to isolate
those filters which allowed the most profilin to pass in the flow through.  Through this
method we were able to find 2 filters.  Next we proceeded with the binding assay
examining 0-30 molar excess G4.  However, upon running the gels, extra bands were
apparent, either from contamination or degradation.  Additionally there is clearly still
protein present on the filters in the final wash between each sample.  This indicates there
could still be protein present on the filter for the next sample which could alter the data.
This data set is represented by trial 5 in Figure 11.  The data does seem to be consistent
with the initial results obtained in trial 1.  Subsequently, this method is currently being
optimized through the use of 8 M urea between each sample to help aid in removal of all
protein.
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Figure 11. Graph showing overlay of all binding filtration assay results to date.  The graph shows bound
protein as a function of G4 concentration.  Trial 1 represents the first set of data collected with this
binding method, while trial 5 represents the most recent where one filter was reused for the entire binding
assay.
Biotinylated G1 PIP2 micelle mimic
 Most of the work done thus far has only examined binding with the larger
dendrimers (ex. G4).  The binding filtration assay is appropriate for this size of dendrimer;
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however, this method would not be expected to work for the smaller dendrimers (ex. G0,
G1, G2).  The combined size of the protein and smaller dendrimer would not be
adequately large enough to remain on the top of the filter.  For this reason, I have
prepared a biotinylated G1 PIP2 micelle mimic.  This dendrimer contains a biotin tether
and 7 PIP2 headgroups.  It is currently being characterized by ESI mass spectrometry and
1 and 2 dimensional 1H NMR.  This dendrimer can be immobilized on a streptavidin chip
and used in SPR experiments to monitor binding with profilin.  Additionally, other sizes of
dendrimers can be made to contain the biotin moiety and will also be used for SPR
experiments.
 Initially, a biotin tether was synthesized as shown in Scheme 1.  Chemistry through
7 was achieved using the methods of Nelson32.  Subsequent addition of the squarate linker
afforded 131.  Additional steps gave the biotinylated G1 squarate PAMAM
HN NH
O
S
HO
O
HN NH
O
S
O
O
F
F
F
F
HN NH
O
S
N
H
O
OOOH2N
HN NH
O
S
N
H
O
OOON
HO
2,3,5,6-Tetraflurophenol
DCC
DMF
80oC
4,7,10-Trioxatridecanediamine
TEA
DMF
3,4-Diethoxy-3-cyclobutene-1,2-
dione
EtOH
O
O
5
6
7
1
Scheme 1. Overview of synthesis of the biotin squarate tether (1).
dendrimer (3).  The 1H NMR of 3 is shown in Figure 12 along with assignments made
based on 1H-1H COSY NMR.  The figure only shows ¼ of the dendrimer; the other ¾ not
shown does not contain the biotin portion.  The reaction of the previously prepared PIP2
headgroup9 with 3 gave the biotinylated G1 PIP2 micelle mimic (4) shown in Figure 13.
This molecule is currently being characterized.
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Figure 12. 1H NMR of biotinylated G1 squarate PAMAM dendrimer (3).  Assignments were made based
on 1H-1H COSY NMR.
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Figure 13.  Structure of biotinylated G1 PIP2 micelle mimic.
Conclusions and Future Work
 In conclusion, I have begun to examine the binding interaction between PIP2 and
the PIP2 G4 dendrimer with profilin by using SPR, ITC, and a binding filtration assay.
Upon examining what has previously been done, several possible experiments could still be
done to examine the binding between PIP2 and profilin using SPR.  Additional experiments
would include the reexamination of the amine coupling of the wild type profilin.  It is
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possible to incorporate a running and storage buffer which includes 1 or 2 mM DTT.  This
would ensure longer stability of profilin when coupled to the chip.  I also believe that
previous regeneration conditions would still be applicable in this experiment.  It might
simply be best to derivatize the chip and carry out the binding experiments in a relatively
short period of time, i.e. 1 or 2 days.  Additional SPR experiments would involve the
coupling of the biotinylated G1 PIP2 mimic and evaluation of binding with profilin.  Lastly
the binding filtration assay can be repeated with the 8 M urea wash in between samples.
631
Reference List
 1.  Toker, A. Phosphoinositides and signal transduction. Cell Mol. Life Sci. 2002, 59,
761-779.
 2.  Janmey, P. Protein regulation by phosphatidylinositol lipids. Chem. Biol. 1995, 2,
61-65.
 3.  Yin, H. L.; Janmey, P. A. Phosphoinositide regulation of the actin cytoskeleton.
Annu. Rev. Physiol 2003, 65, 761-789.
 4.  Ferrell, J. D. J.; Huestis, W. H. Phosphoinositide metabolism and the morphology of
human erythrocytes. J. Cell Biol. 1984, 98, 1992-1.
 5.  Hagelberg C; Allan D Restricted diffusion of integral membrane proteins and
polyphosphoinsitides leads to their depletion in microvesicles released from
human erythrocytes. Biochem. J. 1990, 271, 831-834.
 6.  DiNitto, J. P.; Cronin, T. C.; Lambright, D. G. Membrane recognition and targeting
by lipid-binding domains. Sci. STKE. 2003, 213, 1-15.
 7.  Lemmon, M. A. Phosphoinositide binding domains. Traffic 2003, 4, 201-213.
 8.  Niggli V. Structural properties of lipid-binding sites in cytoskeletal proteins. Trends
Biochem. Sci. 2001, 26 (10), 604-611.
 9.  Webb, S. A. Synthesis and Characterization of Multivalent Mimics of
Phosphatidylinositol-4,5-bisphosphate (PIP2) Micelles. 2004.
 10.  Ostrander, D. B.; Gorman, J. A.; Carman, G. M. Regulation of profilin localization
in Saccharomyces cerevisiae by phosphoinositide metabolism. J. Biol. Chem.
1995, 270 (45), 27045-27050.
 11.  Goldschmidt-Clermont, P. J.; Machesky, L. M.; Doberstein, S. K.; Pollard, T. D.
Mechanism of the interaction of human platelet profilin with actin. J. Biol.
Chem. 1991, 113 (5), 1081-1089.
 12.  Wittenmayer, N.; Jandrig, B.; Rothkegel, M.; Schluter, K.; Arnold, W.; Haensch,
W.; Scherneck, S.; Jockusch, B. M. Tumor suppressor activity of profilin
requires a functional actin binding site. Mol. Biol. Cell 2004, 15 (4), 1600-
1608.
 13.  Sohn, R. H.; Chen, J.; Koblan, K. S.; Bray, P. F.; Goldschmidt-Clermont, P. J.
Localization of a binding site for phosphatidylinositol 4,5-bisphosphate on
human profilin. J. Biol. Chem. 1995, 270 (36), 21114-21120.
632
 14.  Chaudhary, A.; Chen, J.; Gu, Q. M.; Witke, W.; Kwiatkowski, D. J.; Prestwich, G.
D. Probing the phosphoinositide 4,5-bisphosphate binding site of human
profilin I. Chem. Biol. 1998, 5 (5), 273-281.
 15.  Yu, F.-X.; Sun, H. Q.; Janmey, P.; Yin, H. L. Identification of a
polyphosphoinositide binding sequence in an actin monomer-binding domain
of gelsolin. J. Biol. Chem. 1992, 267, 14616-14621.
 16.  Fedorov, A. A.; Magnus, K. A.; Graupe, M. H.; Lattman, E. E.; Pollard, T. D.;
Almo, S. C. X-ray structures of isoforms of the actin-binding protein profilin
that differ in their affinity for phosphatidylinositol phosphates. Proc. Natl.
Acad. Sci. U. S. A 1994, 91, 8636-8640.
 17.  Raghunathan, V.; Mowery, P.; Rozycki, M.; Lindberg, U.; Schutt, C. Structural
changes in profilin accompany its binding to phosphatidylinositol, 4,5-
bisphosphate. FEBS Lett. 1992, 297 (1-2), 46-50.
 18.  Lassing, I.; Lindberg, U. Specific interaction between phsophatidylinositol 4,5-
bisphosphate and profilactin. Nature 1985, 314, 835-838.
 19.  Goldschmidt-Clermont, P. J.; Machesky, L. M.; Baldassare, J. J.; Pollard, T. D. The
actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by
phospholipase C. Science 1990, 247 (4950), 1575-1578.
 20.  Machesky, L. M.; Goldschmidt-Clermont, P. J.; Pollard, T. D. The affinities of
human platelet and Acanthamoeba profilin isoforms for
polyphosphoinositides account for their relative abilities to inhibit
phospholipase C. Cell Regul. 1990, 1 (12), 937-950.
 21.  Mammen, M.; Seok-Ki, C.; Whitesides, G. M. Polyvalent Interactions in Biological
Systems: Implications for Design and
Use of Multivalent Ligands and Inhibitors. Angew. Chem. Int. Ed. Engl.
1998, 37, 2754-2794.
 22.  Kitov, P. I.; Sadowska, J. M.; Mulvey, G.; Armstrong, G. D.; Ling, H.; Pannu, N.
S.; Read, R. J.; Bundle, D. R. Shiga-like toxins are neutralized by tailored
multivalent carbohydrate ligands. Nature 2000, 403, 669-672.
 23.  Woller, E. K.; Cloninger, M. J. The lectin-binding properties of six generations of
mannose-functionalized dendrimers. Org. Lett. 2002, 4 (1), 7-10.
 24.  Tomalia, D. A.; Naylor, A. M.; Goddard III, W. A. Starburst Dendrimers:
Molecular-Level Control of Size, Shape, Surface Chemistry, Topology, and
Flexibility from Atoms to Macroscopic Matter. Angew. Chem. Int. Ed. Engl.
1990, 29, 138-175.
633
 25.  Webb, S. A.; Stewart, N. K.; Belcher, L. J.; Mechref, Y.; Tomaszewski, J. W.;
Novotny, M. V.; Oakley, M. G. Synthesis and characterization of synthetic
PIP2 micelles. Unpublished Work, 2006.
 26.  Fedorov, A. A.; Pollard, T. D.; Almo, S. C. Purification, characterization and
cyrstallization of human platelet profilin expressed in Escherichia coli. J.
Mol. Biol. 1994, 241, 480-482.
 27.  Mehrotra, B.; Myszka, D. G.; Prestwich, G. D. Binding kinetics and ligand
specificity for the interactions of the C2B domain of synaptogmin II with
inositol polyphosphates and phosphoinositides. Biochemistry 2000, 39,
9679-9686.
 28.  Machesky, L. M.; Cole, N. B.; Moss, B.; Pollard, T. D. Vaccinia virus expresses a
novel profilin with a higher affinity for polyphosphoinositides than actin.
Biochemistry 1994, 33 (35), 10815-10824.
 29.  Lambrechts, A.; Verschelde, J. L.; Jonckheere, V.; Goethals, M.; Vandekerckhove,
J.; Ampe, C. The mammalian profilin isoforms display complementary
affinities for PIP2 and proline-rich sequences. EMBO J. 1997, 16 (3), 484-
494.
 30.  Molecular Probes, I. d. t.  SYPRO Ruby protein gel stain product information.
2005.
Ref Type: Pamphlet
 31.  Tietze, L. F.; Arlt, M.; Beller, M.; Glusenkamp, K.; Jahde, E.; Rajewsky, M. F.
Squaric acid diethyl ester: A new coupling reagent for the formation of drug
biopolymer conjugates.  Synthesis of squaric acid ester amides and diamides.
Chem. Ber. 1991, 124, 1215-1221.
 32.  Nelson, K. E.; et al. Surface characterization of mixed self-assembled monolayers
designed for Streptavidin immobilization. Langmuir 2001, 17, 2807-2816.
